ERD

A Large Cohort of RAG1/2-Deficient SCID Patients—Clinical, Immunological, and Prognostic Analysis

Project: RECOMB

Updated at: 29-04-2024

Show more information

Project acronym RECOMB

A Small Key for a Heavy Door: Genetic Therapies for the Treatment of Hemoglobinopathies

Project: RECOMB

Updated at: 29-04-2024

Show more information

Project acronym RECOMB

Preclinical Development of Autologous Hematopoietic Stem Cell-Based Gene Therapy for Immune Deficiencies: A Journey from...

Project: RECOMB

Updated at: 29-04-2024

Show more information

Project acronym RECOMB

Targeted Repair of p47-CGD in iPSCs by CRISPR/Cas9: Functional Correction without Cleavage in the Highly Homologous Pseu...

Project: RECOMB

Updated at: 29-04-2024

Show more information

Project acronym RECOMB

Innovative Cell-Based Therapies and Conditioning to Cure RAG Deficiency

Project: RECOMB

Updated at: 29-04-2024

Show more information

Project acronym RECOMB

RECOMB Website

Project: RECOMB

Updated at: 29-04-2024

Show more information

Project acronym RECOMB

Predicting genotoxicity of viral vectors for stem cell gene therapy using gene expression-based machine learning

Project: RECOMB

Updated at: 29-04-2024

Show more information

Project acronym RECOMB

Lentiviral Vector Gene Therapy in Rag1 Hypomorphic Mice: Treating Immunodeficiency in the Context of Immune Dysregulatio...

Project: RECOMB

Updated at: 29-04-2024

Show more information

Project acronym RECOMB

Efficacy assessment of lentiviral vector gene therapy in the immune dysregulated hypomorphic Rag1 mice

Project: RECOMB

Updated at: 29-04-2024

Show more information

Project acronym RECOMB

The quest for the holy grail: overcoming challenges in expanding human hematopoietic stem cells for clinical use.

Project: RECOMB

Updated at: 29-04-2024

Show more information

Project acronym RECOMB

An adequate human T cell repertoire from a single T cell progenitor: Lessons from an experiment of nature.

Project: RECOMB

Updated at: 29-04-2024

Show more information

Project acronym RECOMB

Manufacturing Lentiviral Vector as Gene Therapy for RAG1-SCID

Project: RECOMB

Updated at: 29-04-2024

Show more information

Project acronym RECOMB

Periodic Reporting for period 4 - RECOMB (Stem-cell based gene therapy for recombination deficient SCID (RECOMB))

Project: RECOMB

Updated at: 29-04-2024

Show more information

Project acronym RECOMB

Successful Preclinical Development of Gene Therapy for Recombinase-Activating Gene-1-Deficient SCID

Project: RECOMB

Updated at: 29-04-2024

Show more information

Project acronym RECOMB

A Novel Branched DNA-Based Flowcytometric Method for Single-Cell Characterization of Gene Therapy Products and Expressio...

Project: RECOMB

Updated at: 29-04-2024

Show more information

Project acronym RECOMB

Genomic Engineering in Human Hematopoietic Stem Cells: Hype or Hope?

Project: RECOMB

Updated at: 29-04-2024

Show more information

Project acronym RECOMB

Use of Cell and Genome Modification Technologies to Generate Improved “Off-the-Shelf” CAR T and CAR NK Cells

Project: RECOMB

Updated at: 29-04-2024

Show more information

Project acronym RECOMB

Cell intrinsic regulation of external hematopoietic stem cell stress

Project: RECOMB

Updated at: 29-04-2024

Show more information

Project acronym RECOMB

Inflammation and Wnt Signaling: Target for Immunomodulatory Therapy?

Project: RECOMB

Updated at: 29-04-2024

Show more information

Project acronym RECOMB

SIDUS® technology for viral vector manufacturing

Project: RECOMB

Updated at: 29-04-2024

Show more information

Project acronym RECOMB

Genetic Correction of IL-10RB Deficiency Reconstitutes Anti-Inflammatory Regulation in iPSC-Derived Macrophages.

Project: RECOMB

Updated at: 29-04-2024

Show more information

Project acronym RECOMB

The Route of Early T Cell Development: Crosstalk between Epigenetic and Transcription Factors

Project: RECOMB

Updated at: 29-04-2024

Show more information

Project acronym RECOMB

IL3 has a detrimental effect on hematopoietic stem cell self-renewal in transplantation settings

Project: RECOMB

Updated at: 29-04-2024

Show more information

Project acronym RECOMB

Single-cell immune profiling reveals thymus-seeding populations, T cell commitment, and multilineage development in the ...

Project: RECOMB

Updated at: 29-04-2024

Show more information

Project acronym RECOMB

Multi-omic analyses in immune cell development with lessons learned from T cell development.

Project: RECOMB

Updated at: 29-04-2024

Show more information

Project acronym RECOMB

The recombinase activating genes: architects of immune diversity during lymphocyte development.

Project: RECOMB

Updated at: 29-04-2024

Show more information

Project acronym RECOMB

Resources

Selected filters:

A Large Cohort of RAG1/2-Deficient SCID Patients—Clinical, Immunological, and Prognostic Analysis

A Small Key for a Heavy Door: Genetic Therapies for the Treatment of Hemoglobinopathies

Preclinical Development of Autologous Hematopoietic Stem Cell-Based Gene Therapy for Immune Deficiencies: A Journey from...

Targeted Repair of p47-CGD in iPSCs by CRISPR/Cas9: Functional Correction without Cleavage in the Highly Homologous Pseu...

Innovative Cell-Based Therapies and Conditioning to Cure RAG Deficiency

RECOMB Website

Predicting genotoxicity of viral vectors for stem cell gene therapy using gene expression-based machine learning

Lentiviral Vector Gene Therapy in Rag1 Hypomorphic Mice: Treating Immunodeficiency in the Context of Immune Dysregulatio...

Efficacy assessment of lentiviral vector gene therapy in the immune dysregulated hypomorphic Rag1 mice

The quest for the holy grail: overcoming challenges in expanding human hematopoietic stem cells for clinical use.

An adequate human T cell repertoire from a single T cell progenitor: Lessons from an experiment of nature.

Manufacturing Lentiviral Vector as Gene Therapy for RAG1-SCID

Periodic Reporting for period 4 - RECOMB (Stem-cell based gene therapy for recombination deficient SCID (RECOMB))

Successful Preclinical Development of Gene Therapy for Recombinase-Activating Gene-1-Deficient SCID

A Novel Branched DNA-Based Flowcytometric Method for Single-Cell Characterization of Gene Therapy Products and Expressio...

Genomic Engineering in Human Hematopoietic Stem Cells: Hype or Hope?

Use of Cell and Genome Modification Technologies to Generate Improved “Off-the-Shelf” CAR T and CAR NK Cells

Cell intrinsic regulation of external hematopoietic stem cell stress

Inflammation and Wnt Signaling: Target for Immunomodulatory Therapy?

SIDUS® technology for viral vector manufacturing

Genetic Correction of IL-10RB Deficiency Reconstitutes Anti-Inflammatory Regulation in iPSC-Derived Macrophages.

The Route of Early T Cell Development: Crosstalk between Epigenetic and Transcription Factors

IL3 has a detrimental effect on hematopoietic stem cell self-renewal in transplantation settings

Single-cell immune profiling reveals thymus-seeding populations, T cell commitment, and multilineage development in the ...

Multi-omic analyses in immune cell development with lessons learned from T cell development.

The recombinase activating genes: architects of immune diversity during lymphocyte development.